Summary
Agilent Technologies, Inc. filed its 2000 Annual Report (10-K) on January 17, 2001, detailing its business operations, financial performance, and strategic outlook. The company, a spin-off from Hewlett-Packard, operates primarily in measurement and chemical analysis sectors, serving diverse markets including life sciences, diagnostics, and applied chemical industries. Investors should note Agilent's focus on innovation and its position within rapidly evolving technological fields.
Key Highlights
- 1Agilent Technologies was established as an independent, publicly traded company following its spin-off from Hewlett-Packard in November 1999.
- 2The company's core businesses are organized into three main segments: Life Sciences and Diagnostics, Semiconductor Products, and Test and Measurement.
- 3Agilent's product portfolio includes a wide range of instruments, software, services, and consumables critical for research, clinical, and industrial applications.
- 4The report emphasizes Agilent's commitment to research and development to maintain its competitive edge in technology-driven markets.
- 5Key financial information is presented, including selected financial data and management's discussion and analysis of financial condition and results of operations, providing insights into the company's performance and outlook.
- 6Market risk disclosures are provided, outlining the company's exposure to various market factors and its strategies to manage these risks.
Frequently Asked Questions
As of the fiscal year ending in 2000, Agilent Technologies operated through three primary segments: Life Sciences and Diagnostics, Semiconductor Products, and Test and Measurement. These segments serve a broad range of industries and scientific disciplines.
Agilent Technologies was formed as an independent, publicly traded company through a spin-off from Hewlett-Packard. This separation was completed in November 1999, allowing Agilent to focus on its specific technology markets.
Agilent focuses on providing advanced instruments, software, services, and consumables primarily for the life sciences, diagnostics, and applied chemical industries. Its offerings are crucial for research, laboratory analysis, and manufacturing processes.
While specific details are within the full report, the filing indicates that Agilent, like many technology companies, faces market risks. This includes potential impacts from economic conditions, competitive pressures, technological obsolescence, and global economic factors. The 'Quantitative and Qualitative Disclosures About Market Risk' section (Item 7A) would provide more specific details.